Bottom line
SPUC vs CRDBX: the short answer
SPUC (Simplify US Equity PLUS Upside Convexity ETF) and CRDBX (Potomac Defensive Bull Fund) share a meaningful slice of their top holdings — about 77% by weight.
SPUC is cheaper at 0.53% vs 1.22% — a difference of $69 a year per $10,000 invested.
Over five years, CRDBX returned +16.0% a year vs +14.6% for SPUC.
Updated Nov 19, 2026
SPUC vs CRDBX side by side
| SPUC | CRDBX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Simplify Exchange Traded | Pfs |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.53% | 1.22% |
| Annual cost per $10k | $53 | $122 |
| 10-yr cost on $10k (prospectus) | $665 | $1,477 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +22.6% | +25.4% |
| 5-yr return (annualized) | +14.6% | +16.0% |
| 10-yr return (annualized) | — | — |
| Best quarter | +18.7% | +19.5% |
| Worst quarter | −17.8% | −21.1% |
| Net assets (fund) | $92.0M | $3.7B |
| Number of holdings | 4 | 4 |
| Portfolio turnover | 64% | 1,275% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SPUC | CRDBX | Difference |
|---|---|---|---|
| 2025 | +22.6% | +25.4% | −2.8% |
| 2024 | +25.3% | +19.8% | +5.5% |
| 2023 | +27.5% | +19.1% | +8.3% |
| 2022 | −24.6% | −8.5% | −16.1% |
| 2021 | +33.9% | +28.2% | +5.6% |
Source: Fund prospectus bar charts
Holdings overlap
1 of SPUC's top 4 holdings also appear in CRDBX's top 4.
| Holding | SPUC | CRDBX |
|---|---|---|
| Ishares Trust | 99.70% | 72.28% |
Source: SEC Form N-PORT
SPUC top 10
- Ishares Trust — 99.70%
- The Options Clearing Corporation — 0.59%
- Dreyfus Trsy Oblig Cash M — 0.07%
- The Options Clearing Corporation — -0.31%
CRDBX top 10
- iShares Trust — 72.28%
- State Street Institutional Investment Trust — 11.49%
- BondBloxx ETF Trust — 9.23%
- Chicago Mercantile Exchange — 0.56%
FAQ
What is the difference between SPUC and CRDBX?
Which is cheaper, SPUC or CRDBX?
Should I own both SPUC and CRDBX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.